Company Description
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.
Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D.
The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers.
OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
| Country | United States |
| Founded | 2007 |
| IPO Date | Oct 12, 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 562 |
| CEO | David Bailey |
Contact Details
Address: 2850 Frontier Drive Warsaw, Indiana 46582 United States | |
| Phone | 574 268 6379 |
| Website | orthopediatrics.com |
Stock Details
| Ticker Symbol | KIDS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001425450 |
| CUSIP Number | 68752L100 |
| ISIN Number | US68752L1008 |
| Employer ID | 26-1761833 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David R. Bailey | President, Chief Executive Officer and Director |
| Mark C. Throdahl | Executive Chairman |
| Fred L. Hite | Chief Financial Officer, Principal Financial and Accounting Officer, Chief Operating Officer and Director |
| Daniel J. Gerritzen J.D. | Executive Vice President of Legal, General Counsel and Secretary |
| Gregory A. Odle | President of Scoliosis |
| Joseph W. Hauser | President of Trauma, Deformity Correction and OPSB |
| Kevin L. Unger CHE, MBA/MSHA | President of Enabling Technologies |
| Mark Karshner | Senior Vice President of International Sales |
| Ray Garrison | Senior Vice President of Quality and Regulatory and Clinical |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2025 | DEFR14A | Filing |
| Apr 2, 2025 | ARS | Filing |
| Apr 2, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 2, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 6, 2025 | 8-K | Current Report |
| Mar 5, 2025 | 10-K | Annual Report |
| Mar 4, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Jan 14, 2025 | 8-K | Current Report |
| Jan 13, 2025 | 8-K | Current Report |